AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $134,700 | +79.2% | 9,919 | 0.0% | 0.03% | -29.3% |
| Q1 2020 | $75,186 | +19.9% | 9,919 | 0.0% | 0.04% | +41.4% |
| Q4 2019 | $62,688 | +61.2% | 9,919 | 0.0% | 0.03% | +45.0% |
| Q3 2019 | $38,882 | -19.0% | 9,919 | 0.0% | 0.02% | -20.0% |
| Q2 2019 | $48,008 | -40.9% | 9,919 | 0.0% | 0.02% | -43.2% |
| Q1 2019 | $81,237 | – | 9,919 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |